Pool Strategy for Surveillance Testing of SARS-CoV-2

REVIEW

  • Felipe Marceca University of Vienna
  • Luciana Rocha Viegas IFIBYNE - CONICET
  • Nicolas Pregi IQUIBICEN - CONICET
  • María Gabriela Barbas Health Ministry of Córdoba
  • Daniela Hozbor IBBM - UNLP - CONICET
  • Adali Pecci IFIBYNE - CONICET
  • Roberto Etchenique DQIAyQF - INQUIMAE - FCEyN - UBA

Abstract

Due to the great morbidity and mortality in the risk groups of the pandemic COVID-19 caused by the emerging coronavirus SARS-CoV-2 and in the absence of effective therapeutic or preventive measures, quarantines, social distancing and the use of masks were the measures most used by health systems to reduce infections. The social, economic and health impact caused by these measures have begun to be evaluated in the different countries. These analyses lead to underestimations because in general they evaluate disease confirmed by a laboratory test and in some cases by epidemiological link without considering asymptomatic or oligosymptomatic infection. Therefore, mitigating fast circulation of the virus requires continuous tracking, detection, and isolation of cases, for which active surveillance able to address asymptomatic cases can make a valuable contribution over the dynamics of the disease in a given society, and to allocate adequate health resources and evaluate the effectiveness of control measures. Mathematical models such as the Susceptible-Exposed-Infectious-Removed (SEIR) allow not only to improve the estimates of the evolution of the pandemic at the local level, but also to evaluate health strategies. In the context of large testing requirements and the expansion of such testing capacity, it is also essential to develop approaches that improve the efficient use of these resources. Active surveillance undoubtedly contributes to improving estimates of virus circulation and it is of particular importance in vulnerable groups of high population density that have one or more risk factors, difficult access to the health system, and inhabit semi-closed facilities such as residential care homes, mental hospitals, prison houses, police stations housing prisoners, etc. Group testing strategies are especially useful for routine community survey and for monitoring of cohesive groups. While the frequency of infection in a population, who have only some symptoms compatible with the disease or do not have any symptoms, may be low, diagnosing even a single positive person typically requires quarantine of the entire group to prevent further spread in the community. In these surveillance strategies, pooling may allow more routine monitoring and detection of low frequency of carriage, thereby improving estimates, informing policy makers, reducing transmission, and alleviating the strain on healthcare services. By means of molecular tests based on RT-qPCR, the pooling strategy has been assayed with different algorithms also for COVID-19, particularly in the asymptomatic population, since a low prevalence of the disease is expected there. This has increased SARS-CoV-2 testing throughput while maintaining high sensitivity. Here, we discuss the relevance of some active surveillance strategies to determine key facts about COVID-19 pandemics and review different testing strategies that different countries have applied for tracking SARS-CoV-2.

Author Biographies

Felipe Marceca, University of Vienna

Felipe Marceca obtained his degree (2016) and his PhD (2021) in Mathematics from the School of Exact and Natural Sciences at the University of Buenos Aires (FCEN-UBA), Argentina. Currently, he has a postdoctoral position at the University of Vienna, Austria, where he is conducting research in the fields of functional and harmonic analysis.

Luciana Rocha Viegas, IFIBYNE - CONICET

Luciana Rocha Viegas obtained her degree in Biology (2000) and her PhD in Biological Chemistry (2005) from the School of Exact and Natural Sciences at the University of Buenos Aires (FCEN-UBA), Argentina. Currently, she is Associate Investigator of CONICET at the Laboratory of Nuclear Receptors and Chromatin at the Institute of Physiology, Molecular Biology and Neurosciences (IFIBYNE), CONICET and teaching assistant of molecular and cellular biology at FCEN-UBA.

Nicolas Pregi, IQUIBICEN - CONICET

Nicolás Pregi obtained his degree in Biology (2001, University of Buenos Aires), and has a PhD from the University of Buenos Aires (2007). Nowadays, he works as a researcher at CONICET in the field of neuroepigenetics of stress at the IQUIBICEN (CONICET, Argentina), and as a professor at the National University of San Martín (Buenos Aires, Argentina).

María Gabriela Barbas, Health Ministry of Córdoba

María Gabriela Barbas btained her degree in Biochemistry (1999) and her specialization in virology (2003) from the Chemistry school at the National University of Córdoba (FCQ-UNC), Argentina. She is currently secretary of prevention and health promotion at the Health Ministry of Córdoba, Argentina. Also she was Head of the Central Laboratory of Córdoba, Argentina (since 2007 until 2019); teacher at the chair of microbiology of the Catholic University of Córdoba (since 2014 until 2019); Management consultant of AIDS and STD of the National Health Ministry of Argentina (since 2014 until 2019).

Daniela Hozbor, IBBM - UNLP - CONICET

Daniela Hozbor obtained her degree in Biochemistry (1987) and her PhD in Biochemical Sciences (1993) from La Plata National University (UNLP), Argentina. Currently, she is Senior Investigator of CONICET, Head of the Laboratory of Vaccines (VacSal) at the Institute of Biotechnology and Molecular Biology (IBBM), UNLP-CONICET and full professor of the Biotechnology and Molecular Biology Area of the Faculty of Sciences. UNLP. She is in charge of the Pertussis Reference Laboratory and is a member of the steering committee of the Global Pertussis Initiative.

Adali Pecci, IFIBYNE - CONICET

Adali Pecci obtained her degree in Chemistry (1988) and her PhD in Biological Chemistry (1997) from the School of Exact and Natural Sciences at the University of Buenos Aires (FCEN-UBA), Argentina. Currently, she is Senior Investigator of CONICET, Head of the Laboratory of Nuclear Receptors and Chromatin at the Institute of Physiology, Molecular Biology and Neurosciences (IFIBYNE), CONICET and Associated Professor at Biological Chemistry Department, FCEN-UBA. She is Vice-Director of the IFIBYNE and Academic Officer of FCEN-UBA.

Roberto Etchenique, DQIAyQF - INQUIMAE - FCEyN - UBA

Roberto Etchenique obtained his degree in Chemistry (1994) and his PhD in Inorganic, Analytical and Physical Chemistry (1998) from the School of Exact and Natural Sciences at the University of Buenos Aires (FCEN-UBA), Argentina. Currently, he is Senior Investigator of CONICET, Head of the Molecular Devices Lab at the Institute of Physical Chemistry of Materials, Environment and Energy (INQUIMAE), CONICET and Full Professor at the Inorganic, Analytical and Physical Chemistry Department, FCEN-UBA.

Published
2021-04-28
Section
Articles